Cover Image

Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections

Polymyxin B is used as a last therapeutic option for the treatment of multidrug-resistant Gram-negative bacterial infections. This study aimed to develop a population pharmacokinetic model and limited sampling strategy, a method to estimate the area under the concentration curve (AUC) by using a lim...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peile Wang (Author), Qiwen Zhang (Author), Zhenfeng Zhu (Author), Min Feng (Author), Tongwen Sun (Author), Jing Yang (Author), Xiaojian Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
by: Peile Wang, et al.
Published: (2021)

Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients: A Comparison of the Early and Stable Posttransplant Stages
by: Peile Wang, et al.
Published: (2022)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children
by: Xuedong Jia, et al.
Published: (2022)

Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection
by: Xueyong Li, et al.
Published: (2022)

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
by: Xingchen Bian, et al.
Published: (2022)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
by: Jun Zhang, et al.
Published: (2018)

Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections
by: Luyao Qiao, et al.
Published: (2024)

Bi-Functional Alginate Oligosaccharide-Polymyxin Conjugates for Improved Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections
by: Joana Stokniene, et al.
Published: (2020)

Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections
by: Juan Zeng, et al.
Published: (2024)

Pharmacokinetics and Nephrotoxicity of Polymyxin MRX-8 in Rats: A Novel Agent against Resistant Gram-Negative Bacteria
by: Xingyi Qu, et al.
Published: (2024)

Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients
by: Mengmeng Jia, et al.
Published: (2022)

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
by: Hui Li, et al.
Published: (2022)

A simple HPLC-MS/MS method for the determination of polymyxin B in human plasma and its application in the pharmacokinetic study in elderly patients infected with multidrug-resistant Gram-negative bacteria
by: Sheng Hu, et al.
Published: (2024)

Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria
by: Yan Wang, et al.
Published: (2024)

Polymyxin B-Associated Nephrotoxicity and Its Predictors: A Retrospective Study in Carbapenem-Resistant Gram-Negative Bacterial Infections
by: Xiao-Li Wu, et al.
Published: (2022)

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections-A Cohort Study
by: Yiying Cai, et al.
Published: (2020)

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
by: Zhenping Wu, et al.
Published: (2023)

Gram-Negative Bacterial Lysins
by: Chandrabali Ghose, et al.
Published: (2020)

Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria
by: Hyejin Cho, et al.
Published: (2022)

Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients
by: Ying Li, et al.
Published: (2021)

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia
by: Mark Biagi, et al.
Published: (2019)

Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients
by: Jun Zhang, et al.
Published: (2017)

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
by: Daniele Roberto Giacobbe, et al.
Published: (2020)

Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
by: Chuanhai Wang, et al.
Published: (2022)

Multidrug-resistant Gram-negative bacterial colonization in patients, carriage by healthcare workers and contamination of hospital environments in Ghana
by: Esther Eyram Asare Yeboah, et al.
Published: (2023)

Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients
by: Ruiying Han, et al.
Published: (2021)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
by: Zhenwei Yu, et al.
Published: (2022)

Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infections: A Drug Pair Limiting the Development of Resistance
by: Junwei Wang, et al.
Published: (2023)

Polymyxins: recent advances and challenges
by: Shan Yang, et al.
Published: (2024)

Aggregatibacter actinomycetemcomitans-Gram-Negative Bacterial Pathogen
Published: (2021)

Gram Negative Bacterial Toe Web Intertrigo
by: Laura Atzori, et al.
Published: (2014)

The Efflux Mechanism of Fraxetin-O-Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3/4) as the Important Contributors
by: Zifei Qin, et al.
Published: (2019)

Guanidinylated Polymyxins as Outer Membrane Permeabilizers Capable of Potentiating Rifampicin, Erythromycin, Ceftazidime and Aztreonam against Gram-Negative Bacteria
by: Danzel Marie Ramirez, et al.
Published: (2022)

Prevalence of carbapenem resistance among multidrug-resistant Gram-negative uropathogens
by: Ann A. Elshamy, et al.
Published: (2018)

Clinical response and outcome in patients with multidrug resistant gram-negative infections
by: Masoume Malekolkottab, et al.
Published: (2017)

Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study
by: Xiao-Jun Cai, et al.
Published: (2022)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
by: Xingchen Bian, et al.
Published: (2024)

Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study
by: Jane Wairimu Maina, et al.
Published: (2023)

Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review
by: Usman Abubakar, et al.
Published: (2023)

Epidemiology, Clinical, and Microbiological Characteristics of Multidrug-Resistant Gram-Negative Bacteremia in Qatar
by: Hamad Abdel Hadi, et al.
Published: (2024)